Trial Search Results

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University


  • Procedure: blood draw


1. Age > or = 18; for the samples collected under the NIH grant, no subjects below the
   age of 20 will be enrolled.

   2. Prior diagnosis of cancer or suspected of having cancer

   3. Karnofsky performance status of greater than 70

   4. Standard pretreatment evaluation

   5. Signed Stanford University Human Subjects Committee consent

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sonya Aggarwal